Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Feb 7 2025

Full Issue

Viewpoints: Clinical Trial Diversity Is Essential, Must Be Reinstated; Nursing Home Staffing Rules Are Crucial

Editorial writers discuss the following public health topics.

Stat: Trump Admin's Removal Of Clinical Trial Diversity Guidelines Hurts Patients 

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the FDA’s Diversity Action Plan guidelines — requiring pharmaceutical companies to test drugs on diverse populations before approval — has been down since Jan. 23. These guidelines were established under the Food and Drug Omnibus Reform Act of 2022, enacted by Congress to promote inclusivity in clinical trials. It’s upsetting to see. But I predict those mandates will eventually come back — because we need them. (Suzanne B. Robotti, 2/6)

The New York Times: Nursing Homes Owe More To Their Residents 

For anyone who lives in a nursing home, the adequacy of the nursing staff is a life-or-death issue. That’s why the Biden administration issued federal rules last year setting minimum standards for staffing. By our estimate, they will save 13,000 lives a year. But those rules are now under attack. (Norma B. Coe and Rachel M. Werner, 2/7)

Stat: Life Sciences Has A Cryostorage Problem 

Three years ago, I was working at a biotech company leading a drug discovery program focused on metabolic disease. Interested in obtaining liver samples that could help identify potential therapeutic targets, I learned that a tenured professor at a top 10 NIH institution had more than 2,000 samples of tissue from patients they had accumulated over more than a decade of research. (Saif Rathore, 2/7)

Chicago Tribune: What Rolling Back Medicaid Expansion Would Do To Illinoisans

Imagine standing at the pharmacy counter, knowing you need an inhaler to breathe and being forced to choose between spending the rest of your paycheck on an inhaler or rent. Thousands of uninsured Chicagoans have been in this position before, and Medicaid expansion — passed in January 2014 through the Affordable Care Act — provided much needed relief to thousands of Chicagoans. If Congress follows through on the plan by President Donald Trump’s administration to roll back Medicaid expansion, 900,000 Illinoisans could lose their health insurance, and millions more would lose coverage across the country. (Robert Vargas and Tony Christiano, 2/7)

Kansas City Star: Missouri Republicans Push For Abortion Ban, Transgender Vote 

Shock of shocks: Missouri Republicans aren’t much interested in reversing the state’s abortion ban. Quite the opposite, in fact. Show-Me State voters sent a pretty clear message to Jefferson City back in November — choosing, as expected, to undo the existing ban. But GOP officials aren’t just dragging their feet to avoid complying with the results of that vote: They are already pushing for another election, this time to re-ban abortion. (Joel Mathis, 2/7)

Kansas City Star: Missouri, Kansas City Veterans Can Get Help With Asbestos 

With asbestos use dominating most industries in past decades, the number of people diagnosed with exposure-related diseases has been increasing nationwide, including in Missouri. The military sector was no exception from applying asbestos in a plethora of products, and, consequently, military veterans are among the individuals most affected by this carcinogenic material, with many developing severe diseases stemming from their exposure, such as asbestosis, mesothelioma or lung cancer. (Cristina Johnson, 2/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF